Top Markets
#1 Palladium Network Palladium Network +27.92%
#2 Siren Siren +24.42%
#3 Ankr Network Ankr Network +21.29%
#4 BankrCoin BankrCoin +18.65%
#5 Status Status +13.53%
#6 Pons Pons +9.90%
#7 Provenance Blockchain Provenance Blockchain +9.18%
#8 Hive Hive +8.50%
#9 Useless Coin Useless Coin +8.27%
#10 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.84%
Coin of the day
Palladium Network Palladium Network
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Orchard Therapeutics plc Orchard Therapeutics plc

Orchard Therapeutics plc

ORTX
Xếp hạng trong cổ phiếu #18160
Orchard Therapeutics plc is a biopharmaceutical firm dedicated to developing... Orchard Therapeutics plc is a biopharmaceutical firm dedicated to developing gene-based treatments for severe and often fatal rare conditions, operating across the United Kingdom, European Union, and the United States. Their innovative gene therapy strategy involves modifying a patient's own hematopoietic stem cells, converting them into a therapeutic cellular drug that can address the illness with just one dose. The company markets Strimvelis, a gammaretroviral therapy approved for treating adenosine deaminase-severe combined immunodeficiency (ADA-SCID). Orchard's clinical pipeline features several investigational therapies, including OTL-101 for ADA-SCID, OTL-200 targeting metachromatic leukodystrophy, OTL-103 for Wiskott-Aldrich syndrome, OTL-102 for X-linked chronic granulomatous disease, and OTL-300 for transfusion-dependent beta-thalassemia. Early-stage research programs encompass OTL-203 for mucopolysaccharidosis type I, OTL-201 for MPS-IIIA, and OTL-202 for MPS IIIB. Furthermore, a strategic partnership with Pharming Group N.V. covers the research, development, production, and commercialization of OTL-105, an experimental ex vivo autologous hematopoietic stem cell gene therapy designed for hereditary angioedema. Established in 2015 as Orchard Rx Limited, Orchard Therapeutics plc is headquartered in London, UK.
Giá cổ phiếu
$16.70
Đồng bộ lần cuối: 2024-02-02
Vốn hóa thị trường
$210.34M
Thay đổi (1 ngày)
0.00%
Thay đổi (1 năm)
0.00%
Quốc gia
GB
Giao dịch Orchard Therapeutics plc (ORTX)

Danh mục

Healthcare
Lịch sử giá cổ phiếu của Orchard Therapeutics plc (ORTX)
Giá đóng cửa cao nhất: $16.70 vào 2024-02-01

Giá đóng cửa thấp nhất: $140.00 vào 2018-10-01
Lịch sử giá cổ phiếu của Orchard Therapeutics plc từ 2018 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2024 2.11%
2023 292.95%
2022 -67.24%
2021 -72.13%
2020 -65.44%
2019 -7.87%
2018 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $556.43 40.29%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 45.39%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $152.82 535.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $123.52 -8.61%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $757.71 6.76%
CH